Volume 24 - Issue 5 - May 2016
Column
Spotlight
06/16/2016
Charles E. Crutchfield III, MD, is a clinical professor of dermatology at the University of Minnesota Medical School.
Charles E. Crutchfield III, MD, is a clinical professor of dermatology at the University of Minnesota Medical School.
Charles E. Crutchfield III, MD,...
06/16/2016
The Dermatologist
Voices
06/13/2016
The Skin Cancer Foundation is poised for growth. New initiatives help reduce the incidence and mortality of the disease.
The Skin Cancer Foundation is poised for growth. New initiatives help reduce the incidence and mortality of the disease.
The Skin Cancer Foundation is...
06/13/2016
The Dermatologist
Department
Research in Review
06/14/2016
One year after its approval, Dr Beer provides an update on clinical experience with deoxycholic acid (Kybella).
One year after its approval, Dr Beer provides an update on clinical experience with deoxycholic acid (Kybella).
One year after its approval, Dr...
06/14/2016
The Dermatologist
The Dermatopathologist
06/13/2016
This case study presents an unusual case of a low-grade eccrine carcinoma showing squamous differentiation.
This case study presents an unusual case of a low-grade eccrine carcinoma showing squamous differentiation.
This case study presents an...
06/13/2016
The Dermatologist
Research in Review
06/08/2016
Isothiazolinones are synthetic biocides/preservatives found in many skin and hair products and industrial products.
Isothiazolinones are synthetic biocides/preservatives found in many skin and hair products and industrial products.
Isothiazolinones are synthetic...
06/08/2016
The Dermatologist
News
News
06/13/2016
Discontinuing nivolumab-ipilimumab treatment because of adverse events may not have a detrimental impact on survival among patients with advanced melanoma, according to follow-up from a randomized trial presented at the American Society of...
Discontinuing nivolumab-ipilimumab treatment because of adverse events may not have a detrimental impact on survival among patients with advanced melanoma, according to follow-up from a randomized trial presented at the American Society of...
Discontinuing...
06/13/2016
The Dermatologist
News
06/10/2016
Results from 3 Phase 3 studies, published in The New England Journal of Medicine, demonstrated the safety and efficacy of ixekizumab (Taltz) for the treatment of moderate to severe plaque psoriasis.
Results from 3 Phase 3 studies, published in The New England Journal of Medicine, demonstrated the safety and efficacy of ixekizumab (Taltz) for the treatment of moderate to severe plaque psoriasis.
Results from 3 Phase 3 studies,...
06/10/2016
The Dermatologist
News
06/09/2016
Positive, top-line results from the second Phase 3 Oral Psoriatic Arthritis Trial (OPAL) Beyond study of tofacitinib citrate (Xeljanz) were recently released.
Positive, top-line results from the second Phase 3 Oral Psoriatic Arthritis Trial (OPAL) Beyond study of tofacitinib citrate (Xeljanz) were recently released.
Positive, top-line results from...
06/09/2016
The Dermatologist
News
06/07/2016
Positive early results from 3 studies using anti-PD-1 therapy pembrolizumab (Keytruda) in combination with various other treatments for advanced melanoma were presented at the 2016 American Society of Clinical Oncology (ASCO) in...
Positive early results from 3 studies using anti-PD-1 therapy pembrolizumab (Keytruda) in combination with various other treatments for advanced melanoma were presented at the 2016 American Society of Clinical Oncology (ASCO) in...
Positive early results from 3...
06/07/2016
The Dermatologist
06/07/2016
This article provides an overview of epidermal grafting and its potential roles in wound care and closure. Cases demonstrating the successful use of epidermal skin grafts over various wound types are also included.
This article provides an overview of epidermal grafting and its potential roles in wound care and closure. Cases demonstrating the successful use of epidermal skin grafts over various wound types are also included.
This article provides an...
06/07/2016
The Dermatologist
